SL JSH 209 : SP ()- SP ()-2 CKD?,2 2 SP ()-3,2 2 2 2 2 SP ()-4 JSH 209CKD SP (2)- CKD 30
SP (2)-2 CKD SP (2)-3 CKD SP (2)-4 CKD SP (2)-5 CKD JSH209 2 3 4 2 3 4 JSH 209 SPRINT SP (3)-,2 2 SP (3)-2 2 3 4 5 2 3 4 5 SP (3)-3 SP (3)-4 The Japanese Society of Hypertension 3
SP (3)-5 2 2 SP (3)-6 ACCORD BP SPRINT SP (3)-7 2 2 JSH-POA Joint session: Systemic hemodynamic atherothrombotic syndrome [Chair] Alberto Avolio (Australia), Hiromi Rakugi (Japan) [Commentator] James Sharman (Australia), Michael O Rourke (Australia) Jeong Bae Park (Korea), Julio A Chirinos (USA) SP - WHAT IS SHATS? Kazuomi Kario (Japan) SP -2 Strain vessel theory; an evolutional point of view Sadayoshi Ito (Japan) SP -3 BP variability and vascular disease Ji-Guang Wang (China) SP -4 Blood pressure variability and organ damage Mitsuru Ohishi (Japan) SP -5 Exercise=severe hemodynamic stress=increased risk Bo Fernhall (USA) SP -6 Hypertension is a System Disruption of Dynamic Blood Pressure Regulation Mediated by Brain Takuya Kishi (Japan) 32
SP - Ca SP -2 Ca 2 Ca 2 SP -3 Ca SP -4 Ca 2 3 4 3 2 3 2 3 4 International FJSH KYOTO Declaration on Hypertension in Asia : Prospects on International FJSH KYOTO Declaration on Hypertension in Asia by the Japanese Society of Hypertension The current status and challenges of hypertension clinical practice in Asian countries and the expected role for Japan Opening remarks Masaaki Ito Keynote Lecture chair Sadayoshi Ito SP -KL How to solve the problem of High Blood Pressure in ASIA. Trefor Morgan Department of Physiology, University of Melbourne. Australia The Japanese Society of Hypertension 33
chair Atsuhiro Ichihara Yusuke Ohya SP - SP -2 SP -3 SP -4 SP -5 Anticipation Telemedicine from Disaster Cardiovascular Protection (DCAP) Network Kazuomi Kario Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine The need for an Asian guideline for the management of hypertension Ji-Guang Wang Cardiovascular medicine in Shanghai Jiaotong University School of Medicine/China Current status and problems of hypertension treatment in Korea. What contributions can we expect from Japan to improve our problems? Sung-Ha Park Division of Cardiology Severance Cardiovascular Hospital Yonsei University College of Medicine, Seoul/Korea 5-year trends of hypertension and other cardiovascular risk factors in Vietnam Quang Ngoc Nguyen Department of Cardiology, Hanoi Medical University/Vietnam Perspectives of salt reduction strategy in Japan. Takuya Tsuchihashi Steel Memorial Yawata Hospital Closing remarks KYOTO Declaration on Hypertension in Asia Sadayoshi Ito Introduction of ifjsh Yusuke Ohya 34
SY- SY-2 SY-3 RAAS SY-4 SGLT2 :? SY2- :? SY2-2 SY2-3 The Japanese Society of Hypertension 35
SY3- SY3-2 SY3-3 SY3-4 SY3-5 SY4- SY4-2,2 2 36
SY4-3 SY4-4 2 3 4 2 3 4 SY4-5 SY5-,2 2 SY5-2 SY5-3 2 2 SY5-4 The Japanese Society of Hypertension 37
SY7- - 2 3 3 2 3 SY7-2 KAMOGAWA HBP cohort study 2 2 2 3 4 5 6 7 8 2 2 3 4 5 6 7 8 SY7-3 ICT 2 2 2 2 SY7-4 -,2 2 3 CAMUI Investigator 4 ASAHI AI Investigator 5 2 3 4 CAMUI Investigator 5 ASAHI AI Investigator 38
SY8- SY8-2,2 2 2 SY8-3 SY8-4 2 2 SY8-5 SY9- AMED- Japan PA Study (JPAS) 2 3 4 5 6 7 7 8 9 0 JPAS 2 3 4 5 6 7 8 9 0 The Japanese Society of Hypertension 39
SY9-2 AVS PA SY9-3 ARR 200 SY9-4 PA Sendai Study 2 2 EL EL2 Up-to-Date 2 2 40
EL3 EL4 EL5 Intrarenal artery ablation with evaluation of denervation 2 2 2 EL6 The Japanese Society of Hypertension 4
EL7 2 2 EL8 M- M-2 2 3 3 3 4 5 6 7 8 8 2 3 4 5 6 7 8 42
M-3 2 2 JA 2 M-4 M2- M2-2 2 3 3 4 4 2 2 3 4 M2-3 Healthy Aging Projects For Women (NPP HAP) M2-4 3 2,3,2,3 2 3 M2-5 2 2 The Japanese Society of Hypertension 43
M3-,2 2 2 M3-2 M3-3,2,2 3 4 3 5 6 6 2 3 4 5 6 M3-4 2 2 2 2 TS 3 44
TS2 RL C0: RL2 C4: RL3 B4: RL4 B4: RL5 A9: The Japanese Society of Hypertension 45
Dr. I vs NS PDS PDS2 PDS3 PDS4 46
ISH2022 Opening remarks Q&A Closing remarks The Japanese Society of Hypertension 47
YCA YCA- AOBP YCA YCA-2,2 2 YCA-3 SAS CR-, CR-2 CR-3 JAK22 literature review 2 2 48
AM- NTT AM-2 XOR,2 3 2 2 3 AM-3 AM-4 SGLT2(PRA) (PAC) (ARR) AM-5 The Japanese Society of Hypertension 49
TM- CKD RAS G4-5 RAS 2 2 2 2 TM-2 2,3 2 3 TM-3 2 2 2 TM-4 TM-5 2 2 2 50
OS- PS- PS-2 PS-3 PS-4 2 KAMOGAWA-HBP study The Japanese Society of Hypertension 5
LS HOMED-BP LS2 / LS3 52
RAAS ARB CCB LS4- LS4-2 RA LS5 The Japanese Society of Hypertension 53
JSH LS6- LS6-2 SOFT Project MS SGLT2 MS2 DPP-4SGLT2 54